COMPASS PATHWAYS PLC Employee Count
The employee counts COMPASS PATHWAYS PLC states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 156; Filing 2026-03-24; Lease expense per employee $15,435.90.
- 2024-12-31: Employees (as filed) 166; Filing 2025-02-27; Lease expense per employee $15,481.93.
- 2023-12-31: Employees (as filed) 186; Filing 2024-02-29; Lease expense per employee $14,032.26.
- 2022-12-31: Employees (as filed) 181; Filing 2023-02-28; Lease expense per employee $13,917.13.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 156 | 2026-03-24 | $15,435.90 total lease cost |
| 2024-12-31 | 166 | 2025-02-27 | $15,481.93 total lease cost |
| 2023-12-31 | 186 | 2024-02-29 | $14,032.26 total lease cost |
| 2022-12-31 | 181 | 2023-02-28 | $13,917.13 total lease cost |
| 2021-12-31 | 116 | 2022-02-24 | $16,637.93 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |